https://orcid.org/0000-0003-1766-7031
References
- WHO . Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021–2030. (2020). www.who.int/publications/i/item/9789240010352
- WHO . Neglected tropical diseases. www.who.int/health-topics/neglected-tropical-diseases
- Ferreira LL , de MoraesJ, AndricopuloAD. Approaches to advance drug discovery for neglected tropical diseases. Drug Discov. Today27(8), 2278–2287 (2022).
- de Moraes J , GearyTG. FDA-approved antiparasitic drugs in the 21st century: a success for helminthiasis?Trends Parasitol.36(7), 573–575 (2022).
- Wouters OJ , McKeeM, LuytenJ. Estimated research and development investment needed to bring a new medicine to market, 2009–2018. JAMA323(9), 844–853 (2020).
- Mengarda AC , IlesB, LongoJPF, de MoraesJ. Recent trends in praziquantel nanoformulations for helminthiasis treatment. Expert. Opin. Drug Deliv.19(4), 383–393 (2022).
- Mengarda AC , IlesB, LongoJPF, de MoraesJ. Recent approaches in nanocarrier-based therapies for neglected tropical diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.e1852 doi: 10.1002/wnan.1852 (2022) ( Epub ahead of print).
- Scannell JW , BlanckleyA, BoldonH, WarringtonB. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov.11(3), 191–200 (2012).
- Gupta R , SrivastavaD, SahuM, TiwariS, AmbastaRK, KumarP. Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol. Divers.25(3), 1315–1360 (2021).
- Wu Q , KeH, LiD, WangQ, FangJ, ZhouJ. Recent progress in machine learning-based prediction of peptide activity for drug discovery. Curr. Top. Med. Chem.19(1), 4–16 (2019).
- Figueiró Longo JP , MuehlmannLA. How has nanomedical innovation contributed to the COVID-19 vaccine development?Nanomedicine16(14), 1179–1181 (2021).
- Longo JPF , MussiS, AzevedoRB, MuehlmannLA. Issues affecting nanomedicines on the way from the bench to the market. J. Mater. Chem. B8(47), 10681–10685 (2020).
- de Lima LI , Py-DanielKR, GuimarãesMAet al. Self-nanoemulsifying drug-delivery systems improve oral absorption and antischistosomal activity of epiisopiloturine. Nanomedicine13(7), 689–702 (2018).
- Galdino de Souza D , SantosDS, SimonKSet al. Fish oil nanoemulsion supplementation attenuates bleomycin-induced pulmonary fibrosis BALB/c mice. Nanomaterials (Basel)12(10), 1683 (2022).
- Santos DS , MoraisJAV, VanderleiÍACet al. Oral delivery of fish oil in oil-in-water nanoemulsion: development, colloidal stability and modulatory effect on in vivo inflammatory induction in mice. Biomed. Pharmacother.133, 110980 (2021).
- El-Moslemany RM , EissaMM, RamadanAA, El-KhordaguiLK, El-AzzouniMZ. Miltefosine lipid nanocapsules: intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni. Acta Trop.159, 142–148 (2016).
- Bern C , Adler-MooreJ, BerenguerJet al. Liposomal amphotericin B for the treatment of visceral leishmaniasis. Clin. Infect. Dis.43(7), 917–924 (2006).